AU Stock MarketDetailed Quotes

RAD Radiopharm Theranostics Ltd

Watchlist
  • 0.032
  • -0.001-3.03%
20min DelayMarket Closed May 31 15:56 AET
14.73MMarket Cap-299P/E (Static)

Radiopharm Theranostics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
118.63%1.85M
-9.92M
Revenue from customers
102.95%292.36K
---9.92M
Other cash income from operating activities
--1.56M
----
Cash paid
-25.19M
Payments to suppliers for goods and services
---25.19M
----
Direct interest received
--145.04K
----
Operating cash flow
-133.99%-23.2M
---9.92M
Investing cash flow
Cash flow from continuing investing activities
94.60%-1.53M
-28.37M
Net PPE purchase and sale
-1,548.09%-45.31K
---2.75K
Net intangibles purchas and sale
94.76%-1.49M
---28.34M
Interest received (cash flow from investment activities)
----
--8.83K
Net other investing changes
----
---40K
Cash from discontinued investing activities
Investing cash flow
94.60%-1.53M
---28.37M
Financing cash flow
Cash flow from continuing financing activities
-85.84%9.22M
65.11M
Net issuance payments of debt
----
---59K
Net common stock issuance
-85.86%9.22M
--65.17M
Cash from discontinued financing activities
Financing cash flow
-85.84%9.22M
--65.11M
Net cash flow
Beginning cash position
99,486.97%26.98M
--27.09K
Current changes in cash
-157.84%-15.51M
--26.82M
Effect of exchange rate changes
84.22%234.65K
--127.37K
End cash Position
-56.64%11.7M
--26.98M
Free cash from
35.35%-24.73M
---38.25M
Accounting Standards
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities 118.63%1.85M-9.92M
Revenue from customers 102.95%292.36K---9.92M
Other cash income from operating activities --1.56M----
Cash paid -25.19M
Payments to suppliers for goods and services ---25.19M----
Direct interest received --145.04K----
Operating cash flow -133.99%-23.2M---9.92M
Investing cash flow
Cash flow from continuing investing activities 94.60%-1.53M-28.37M
Net PPE purchase and sale -1,548.09%-45.31K---2.75K
Net intangibles purchas and sale 94.76%-1.49M---28.34M
Interest received (cash flow from investment activities) ------8.83K
Net other investing changes -------40K
Cash from discontinued investing activities
Investing cash flow 94.60%-1.53M---28.37M
Financing cash flow
Cash flow from continuing financing activities -85.84%9.22M65.11M
Net issuance payments of debt -------59K
Net common stock issuance -85.86%9.22M--65.17M
Cash from discontinued financing activities
Financing cash flow -85.84%9.22M--65.11M
Net cash flow
Beginning cash position 99,486.97%26.98M--27.09K
Current changes in cash -157.84%-15.51M--26.82M
Effect of exchange rate changes 84.22%234.65K--127.37K
End cash Position -56.64%11.7M--26.98M
Free cash from 35.35%-24.73M---38.25M
Accounting Standards US-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg